March 2009 Archives - Silence Therapeutics

News	Events
Publications	Companies
Clinical Trials

Notification of Results
0 Replies

March 30, 2009

Contine Reading & Discuss→

Posted in News and Events

Another LNA-based RNA Inhibitor Enters Clinical Trials
0 Replies

March 20, 2009

EZN3042 – a Survivin inhibitor jointly developed by Enzon Pharmaceuticals and Santaris Pharma advances into the clinic for patients with solid tumors and lymphomas read more Contine Reading & Discuss→

Posted in Companies | Tagged in | Santaris Posted in News | Tagged in | Santaris Posted in Other News | Tagged in | Santaris Posted in Syndicated | Tagged in | Santaris

Holding in Company
0 Replies

March 19, 2009

Contine Reading & Discuss→

Posted in News and Events